Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience. Issue 3 (17th July 2019)
- Record Type:
- Journal Article
- Title:
- Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience. Issue 3 (17th July 2019)
- Main Title:
- Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience
- Authors:
- Mitchell, K G
Nelson, D B
Corsini, E M
Vaporciyan, A A
Antonoff, M B
Mehran, R J
Rice, D C
Roth, J A
Sepesi, B
Walsh, G L
Bhutani, M S
Maru, D M
Wu, C C
Nguyen, Q-N
Ajani, J A
Swisher, S G
Hofstetter, W L - Abstract:
- SUMMARY: The survival advantage associated with the addition of surgical therapy in esophageal squamous cell carcinoma (ESCC) patients who demonstrate a complete clinical response to chemoradiotherapy is unclear, and many institutions have adopted an organ-preserving strategy of selective surgery in this population. We sought to characterize our institutional experience of salvage esophagectomy (for failure of definitive bimodality therapy) and planned esophagectomy (as a component of trimodality therapy) by retrospectively analyzing patients with ESCC of the thoracic esophagus and GEJ who underwent esophagectomy following chemoradiotherapy between 2004 and 2016. Of 76 patients who met inclusion criteria, 46.1% (35) underwent salvage esophagectomy. Major postoperative complications (major cardiovascular and pulmonary events, anastomotic leak [grade ≥ 2], and 90-day mortality) were frequent and occurred in 52.6% of the cohort (planned resection: 36.6% [15/41]; salvage esophagectomy: 71.4% [25/35]). Observed rates of 30- and 90-day mortality for the entire cohort were 7.9% (planned: 7.3% [3/41]; salvage: 8.6% [3/35]) and 13.2% (planned: 9.8% [4/41]; salvage: 17.1% [6/35]), respectively. In summary, esophagectomy following chemoradiotherapy for ESCC at our institution has been associated with frequent postoperative morbidity and considerable rates of mortality in both planned and salvage settings. Although a selective approach to surgery may permit organ preservation in manySUMMARY: The survival advantage associated with the addition of surgical therapy in esophageal squamous cell carcinoma (ESCC) patients who demonstrate a complete clinical response to chemoradiotherapy is unclear, and many institutions have adopted an organ-preserving strategy of selective surgery in this population. We sought to characterize our institutional experience of salvage esophagectomy (for failure of definitive bimodality therapy) and planned esophagectomy (as a component of trimodality therapy) by retrospectively analyzing patients with ESCC of the thoracic esophagus and GEJ who underwent esophagectomy following chemoradiotherapy between 2004 and 2016. Of 76 patients who met inclusion criteria, 46.1% (35) underwent salvage esophagectomy. Major postoperative complications (major cardiovascular and pulmonary events, anastomotic leak [grade ≥ 2], and 90-day mortality) were frequent and occurred in 52.6% of the cohort (planned resection: 36.6% [15/41]; salvage esophagectomy: 71.4% [25/35]). Observed rates of 30- and 90-day mortality for the entire cohort were 7.9% (planned: 7.3% [3/41]; salvage: 8.6% [3/35]) and 13.2% (planned: 9.8% [4/41]; salvage: 17.1% [6/35]), respectively. In summary, esophagectomy following chemoradiotherapy for ESCC at our institution has been associated with frequent postoperative morbidity and considerable rates of mortality in both planned and salvage settings. Although a selective approach to surgery may permit organ preservation in many patients with ESCC, these results highlight that salvage esophagectomy for failure of definitive-intent treatment of ESCC may also constitute a difficult clinical undertaking in some cases. … (more)
- Is Part Of:
- Diseases of the esophagus. Volume 33:Issue 3(2020)
- Journal:
- Diseases of the esophagus
- Issue:
- Volume 33:Issue 3(2020)
- Issue Display:
- Volume 33, Issue 3 (2020)
- Year:
- 2020
- Volume:
- 33
- Issue:
- 3
- Issue Sort Value:
- 2020-0033-0003-0000
- Page Start:
- Page End:
- Publication Date:
- 2019-07-17
- Subjects:
- chemoradiation -- esophagectomy -- ESCC -- squamous cell carcinoma
Esophagus -- Diseases -- Periodicals
616.32 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1442-2050 ↗
http://www.wiley.com/bw/journal.asp?ref=1120-8694 ↗
https://academic.oup.com/dote ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1093/dote/doz067 ↗
- Languages:
- English
- ISSNs:
- 1120-8694
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3598.210000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20851.xml